Innate Pharma S.A. (IPH.PA)

EUR 1.98

(-3.37%)

Annual Balance Sheets

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 184.19 Million 207.86 Million 267.49 Million 307.42 Million 401.36 Million 451.21 Million
Total Current Assets 148.01 Million 139.83 Million 138.25 Million 173.33 Million 237.6 Million 319.64 Million
Cash And Short Term Investments 92.45 Million 101.48 Million 119.83 Million 151.63 Million 218.86 Million 167.53 Million
Cash and Cash Equivalents 70.6 Million 84.22 Million 103.75 Million 136.79 Million 202.88 Million 152.31 Million
Short Term Investments 21.85 Million 17.26 Million 16.08 Million 14.84 Million 15.97 Million 15.21 Million
Net Receivables 46.48 Million 38.34 Million 18.42 Million 21.69 Million 13.14 Million 146.63 Million
Inventory 1.00 -2000.00 -4.94 Million 1.00 5.6 Million 1.00
Other Current Assets 9.06 Million 2000.00 4.94 Million 7.94 Million -1000.00 5.47 Million
Total Non-Current Assets 36.18 Million 68.03 Million 129.24 Million 134.09 Million 163.75 Million 131.57 Million
Net PPE 6.32 Million 8.54 Million 10.17 Million 11.69 Million 11.67 Million 10.21 Million
Good Will And Intangible Assets 416 Thousand 1.55 Million 44.19 Million 46.28 Million 96.96 Million 84.52 Million
Good Will - -40.99 Million 2000.00 1000.00 - -
Intangible Assets 416 Thousand 42.55 Million 44.19 Million 46.28 Million 96.96 Million 84.52 Million
Long-Term Investments 9.79 Million 35.11 Million 39.87 Million 38.93 Million 37 Million 35.18 Million
Tax Assets 9 Million 8.56 Million 5.02 Million 7.08 Million 1.28 Million 1.56 Million
Other Non Current Assets 10.64 Million 14.24 Million 29.96 Million 30.08 Million 16.82 Million 87 Thousand
Other Assets - -1000.00 -1000.00 - - -1000.00
Total Liabilities 132.29 Million 153.71 Million 160.05 Million 151.44 Million 183.94 Million 283.97 Million
Total Current Liabilities 39.63 Million 41.33 Million 79.88 Million 46.69 Million 121.82 Million 196.73 Million
Account Payables 8.56 Million 20.91 Million 28.57 Million 29.53 Million 27.93 Million 41.67 Million
Tax Payables 7.02 Million 5.97 Million 7.46 Million 8.32 Million 6.99 Million 5.66 Million
Short Term Debt 8.93 Million 2.1 Million 30.74 Million 2.14 Million 2.13 Million 1.34 Million
Deferred Revenue 5.86 Million 6.56 Million 12.5 Million 12.5 Million 48.77 Million 82.09 Million
Other Current Liabilities 16.27 Million 11.76 Million 8.06 Million 2.5 Million 42.98 Million 71.61 Million
Total Non Current Liabilities 92.65 Million 112.37 Million 80.17 Million 104.75 Million 62.12 Million 87.23 Million
Long-Term Debt 30.6 Million 40.14 Million 13.5 Million 16.94 Million 16.59 Million 3.17 Million
Deferred Revenue Non Current 4.61 Million 7.92 Million 25.41 Million 31.46 Million 40.34 Million 68.09 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 48.42 Million 55.73 Million 36.22 Million 49.25 Million 3.9 Million 14.4 Million
Other Liabilities - - - - - -
Total Equity 51.9 Million 54.15 Million 107.44 Million 155.97 Million 217.41 Million 167.24 Million
Stock Holders Equity 51.9 Million 54.15 Million 107.44 Million 155.97 Million 217.41 Million 167.24 Million
Common Stock 4.04 Million 4.01 Million 3.97 Million 3.95 Million 3.94 Million 3.19 Million
Retained Earnings -336.89 Million -330.31 Million -272.21 Million -220.46 Million -155.67 Million -134.79 Million
Accumulated other comprehensive income 495 Thousand 819 Thousand 456 Thousand 355 Thousand -472 Thousand -1.09 Million
Common Stock Equity 51.9 Million 54.15 Million 107.44 Million 155.97 Million 217.41 Million 167.24 Million
Capital Lease Obligation 350 Thousand 2.05 Million 2.81 Million 3.53 Million 3.12 Million 2.09 Million
Total Investments 31.64 Million 52.37 Million 55.95 Million 53.77 Million 52.98 Million 35.18 Million
Total Debt 39.89 Million 42.25 Million 44.25 Million 19.08 Million 18.72 Million 4.52 Million
Net Debt -30.71 Million -41.97 Million -59.5 Million -117.7 Million -184.16 Million -147.79 Million

Balance Sheet Charts